Skip to main content
Top
Published in: International Journal of Hematology 1/2015

01-07-2015 | Original Article

Incidence, risk factors, and treatment outcome of symptomatic osteonecrosis in Taiwanese children with acute lymphoblastic leukemia: a retrospective cohort study of 245 patients in a single institution

Authors: Shih-Hsiang Chen, Tsung-Yen Chang, Tang-Her Jaing, Mel S. Lee, Chao-Jan Wang, Iou-Jih Hung, Chao-Ping Yang

Published in: International Journal of Hematology | Issue 1/2015

Login to get access

Abstract

Osteonecrosis (ON) is a potentially disabling complication encountered in children who receive chemotherapy for acute lymphoblastic leukemia (ALL). Considering the possible effect of ethnic difference on the clinical features of symptomatic ON in pediatric ALL, we retrospectively evaluated 245 children with ALL who were treated at Chang Gung Memorial Hospital, Linkou, between 2002 and 2011. Six (2.4 %) patients developed symptomatic ON in a total of 17 sites during the follow-up period. Diagnosis of ON was confirmed by X-ray in seven, magnetic resonance imaging in two, and bone scan in three patients. The estimated cumulative incidence of symptomatic ON in newly diagnosed ALL was 3.4 % at 8 years. Four patients received ON-directed surgical interventions, including total hip replacement in three and arthroplasty in one. The incidence of ON was significantly higher among girls (P = 0.03), patients >10 years old (P = 2.2 × 10−4), and patients who had received more intensive chemotherapy regimen (P = 0.02). These results indicate that the incidence and risk factors in our institute were similar to those observed in Western countries. Future studies surveying the impact on the quality of life of childhood ALL survivors in Taiwan are warranted.
Literature
1.
go back to reference Pui CH, Mullighan CG, Evans WE, Relling MV. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? Blood. 2012;120(6):1165–74.PubMedCentralPubMedCrossRef Pui CH, Mullighan CG, Evans WE, Relling MV. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? Blood. 2012;120(6):1165–74.PubMedCentralPubMedCrossRef
2.
go back to reference Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon PS, Winick NJ, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group. J Clin Oncol. 2012;30(14):1663–9.PubMedCentralPubMedCrossRef Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon PS, Winick NJ, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group. J Clin Oncol. 2012;30(14):1663–9.PubMedCentralPubMedCrossRef
3.
go back to reference Mattano LA Jr, Sather HN, Trigg ME, Nachman JB. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children’s Cancer Group. J Clin Oncol. 2000;18(18):3262–72.PubMed Mattano LA Jr, Sather HN, Trigg ME, Nachman JB. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children’s Cancer Group. J Clin Oncol. 2000;18(18):3262–72.PubMed
4.
go back to reference Ribeiro RC, Fletcher BD, Kennedy W, Harrison PL, Neel MD, Kaste SC, et al. Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma. Leukemia. 2001;15(6):891–7.PubMedCrossRef Ribeiro RC, Fletcher BD, Kennedy W, Harrison PL, Neel MD, Kaste SC, et al. Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma. Leukemia. 2001;15(6):891–7.PubMedCrossRef
5.
go back to reference Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum. 2002;32(2):94–124.PubMedCrossRef Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum. 2002;32(2):94–124.PubMedCrossRef
6.
go back to reference Glueck CJ, Freiberg RA, Fontaine RN, Tracy T, Wang P. Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop Relat Res. 2001;386:19–33.PubMedCrossRef Glueck CJ, Freiberg RA, Fontaine RN, Tracy T, Wang P. Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop Relat Res. 2001;386:19–33.PubMedCrossRef
7.
go back to reference Yamamoto T, Irisa T, Sugioka Y, Sueishi K. Effects of pulse methylprednisolone on bone and marrow tissues: corticosteroid-induced osteonecrosis in rabbits. Arthritis Rheum. 1997;40(11):2055–64.PubMedCrossRef Yamamoto T, Irisa T, Sugioka Y, Sueishi K. Effects of pulse methylprednisolone on bone and marrow tissues: corticosteroid-induced osteonecrosis in rabbits. Arthritis Rheum. 1997;40(11):2055–64.PubMedCrossRef
8.
go back to reference Yun SI, Yoon HY, Jeong SY, Chung YS. Glucocorticoid induces apoptosis of osteoblast cells through the activation of glycogen synthase kinase 3beta. J Bone Miner Metab. 2009;27(2):140–8.PubMedCrossRef Yun SI, Yoon HY, Jeong SY, Chung YS. Glucocorticoid induces apoptosis of osteoblast cells through the activation of glycogen synthase kinase 3beta. J Bone Miner Metab. 2009;27(2):140–8.PubMedCrossRef
9.
go back to reference Faraci M, Calevo MG, Lanino E, Caruso S, Messina C, Favr C, et al. Osteonecrosis after allogeneic stem cell transplantation in childhood. A case-control study in Italy. Haematologica. 2006;91(8):1096–9.PubMed Faraci M, Calevo MG, Lanino E, Caruso S, Messina C, Favr C, et al. Osteonecrosis after allogeneic stem cell transplantation in childhood. A case-control study in Italy. Haematologica. 2006;91(8):1096–9.PubMed
10.
go back to reference Zadegan F, Raould A, Bizot P, Nizard R, Sedel L. Osteonecrosis after allogeneic bone marrow transplantation. Clin Orthop Relat Res. 2008;466(2):287–93.PubMedCentralPubMedCrossRef Zadegan F, Raould A, Bizot P, Nizard R, Sedel L. Osteonecrosis after allogeneic bone marrow transplantation. Clin Orthop Relat Res. 2008;466(2):287–93.PubMedCentralPubMedCrossRef
11.
go back to reference Hyakuna N, Shimomura Y, Watanabe A, Taga T, Kikuta A, Matsushita T, et al. Assessment of corticosteroid-induced osteonecrosis in children undergoing chemotherapy for acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group. J Pediatr Hematol Oncol. 2014;36(1):22–9.PubMedCentralPubMedCrossRef Hyakuna N, Shimomura Y, Watanabe A, Taga T, Kikuta A, Matsushita T, et al. Assessment of corticosteroid-induced osteonecrosis in children undergoing chemotherapy for acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group. J Pediatr Hematol Oncol. 2014;36(1):22–9.PubMedCentralPubMedCrossRef
12.
go back to reference Chen SH, Yang CP, Jaing TH, Hung IJ, Shih LY, Ho PC, et al. Clinical impact of in vitro cellular drug resistance on childhood acute lymphoblastic leukemia in Taiwan. Leuk Lymphoma. 2012;53(8):1536–42.PubMedCrossRef Chen SH, Yang CP, Jaing TH, Hung IJ, Shih LY, Ho PC, et al. Clinical impact of in vitro cellular drug resistance on childhood acute lymphoblastic leukemia in Taiwan. Leuk Lymphoma. 2012;53(8):1536–42.PubMedCrossRef
13.
go back to reference Liang DC, Yang CP, Lin DT, Hung IJ, Lin KH, Chen JS, et al. Long-term results of Taiwan Pediatric Oncology Group studies 1997 and 2002 for childhood acute lymphoblastic leukemia. Leukemia. 2010;24(2):397–405.PubMedCrossRef Liang DC, Yang CP, Lin DT, Hung IJ, Lin KH, Chen JS, et al. Long-term results of Taiwan Pediatric Oncology Group studies 1997 and 2002 for childhood acute lymphoblastic leukemia. Leukemia. 2010;24(2):397–405.PubMedCrossRef
14.
go back to reference Strauss AJ, Su JT, Dalton VM, Gelber RD, Sallan SE, Silverman LB. Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol. 2001;19(12):3066–72.PubMed Strauss AJ, Su JT, Dalton VM, Gelber RD, Sallan SE, Silverman LB. Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol. 2001;19(12):3066–72.PubMed
15.
go back to reference Arico M, Boccalatte MF, Silvestri D, Barisone E, Messina C, Chiesa R, et al. Osteonecrosis: an emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica. 2003;88(7):747–53.PubMed Arico M, Boccalatte MF, Silvestri D, Barisone E, Messina C, Chiesa R, et al. Osteonecrosis: an emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica. 2003;88(7):747–53.PubMed
16.
go back to reference Burger B, Beier R, Zimmermann M, Beck JD, Reiter A, Schrappe M. Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)—experiences from trial ALL-BFM 95. Pediatr Blood Cancer. 2005;44(3):220–5.PubMedCrossRef Burger B, Beier R, Zimmermann M, Beck JD, Reiter A, Schrappe M. Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)—experiences from trial ALL-BFM 95. Pediatr Blood Cancer. 2005;44(3):220–5.PubMedCrossRef
17.
go back to reference Kawedia JD, Kaste SC, Pei D, Panetta JC, Cai X, Cheng C, et al. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. Blood. 2011;117(8):2340–7.PubMedCentralPubMedCrossRef Kawedia JD, Kaste SC, Pei D, Panetta JC, Cai X, Cheng C, et al. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. Blood. 2011;117(8):2340–7.PubMedCentralPubMedCrossRef
18.
go back to reference te Winkel ML, Pieters R, Hop WC, de Groot-Kruseman HA, Lequin MH, van der Sluis IM, et al. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia. J Clin Oncol. 2011;29(31):4143–50.CrossRef te Winkel ML, Pieters R, Hop WC, de Groot-Kruseman HA, Lequin MH, van der Sluis IM, et al. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia. J Clin Oncol. 2011;29(31):4143–50.CrossRef
19.
go back to reference Sharma S, Leung WH, Deqing P, Yang J, Rochester R, Britton L, et al. Osteonecrosis in children after allogeneic hematopoietic cell transplantation: study of prevalence, risk factors and longitudinal changes using MR imaging. Bone Marrow Transplant. 2012;47(8):1067–74.PubMedCentralPubMedCrossRef Sharma S, Leung WH, Deqing P, Yang J, Rochester R, Britton L, et al. Osteonecrosis in children after allogeneic hematopoietic cell transplantation: study of prevalence, risk factors and longitudinal changes using MR imaging. Bone Marrow Transplant. 2012;47(8):1067–74.PubMedCentralPubMedCrossRef
20.
go back to reference Chen SH, Hung IJ, Yang CP, Jaing TH, Fang EC, Yang SH, et al. Allogeneic related bone marrow transplantation in children—a single center experience. Acta Paediatr Taiwan. 2005;46(6):352–5.PubMed Chen SH, Hung IJ, Yang CP, Jaing TH, Fang EC, Yang SH, et al. Allogeneic related bone marrow transplantation in children—a single center experience. Acta Paediatr Taiwan. 2005;46(6):352–5.PubMed
21.
go back to reference Yang YL, Lu MY, Jou ST, Lin KH, Lin DT. Matched-unrelated-donor bone marrow transplantation for children with leukemia. J Formos Med Assoc. 2005;104(6):448–51.PubMed Yang YL, Lu MY, Jou ST, Lin KH, Lin DT. Matched-unrelated-donor bone marrow transplantation for children with leukemia. J Formos Med Assoc. 2005;104(6):448–51.PubMed
22.
go back to reference Chen PM, Hsiao LT, Tang JL, Yen CC, Liu JH, Lin KH, et al. Haematopoietic stem cell transplantation in Taiwan: past, present, and future. Hong Kong Med J. 2009;15(3 Suppl 3):13–6.PubMed Chen PM, Hsiao LT, Tang JL, Yen CC, Liu JH, Lin KH, et al. Haematopoietic stem cell transplantation in Taiwan: past, present, and future. Hong Kong Med J. 2009;15(3 Suppl 3):13–6.PubMed
23.
go back to reference te Winkel ML, Appel IM, Pieters R, van den Heuvel-Eibrink MM. Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia. Haematologica. 2008;93(10):1570–4.CrossRef te Winkel ML, Appel IM, Pieters R, van den Heuvel-Eibrink MM. Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia. Haematologica. 2008;93(10):1570–4.CrossRef
24.
go back to reference De Aragao AP, Lemos RB, Aquino MZ, Souza Marques HH. Hyperlipidaemia a risk factor for femoral head osteonecrosis (Legg-Calv-Perthes-like disease) in children with AIDS: case report. Braz J Infect Dis. 2002;6(3):142–5.CrossRef De Aragao AP, Lemos RB, Aquino MZ, Souza Marques HH. Hyperlipidaemia a risk factor for femoral head osteonecrosis (Legg-Calv-Perthes-like disease) in children with AIDS: case report. Braz J Infect Dis. 2002;6(3):142–5.CrossRef
25.
go back to reference Bhojwani D, Darbandi R, Pei D, Ramsey LB, Chemaitilly W, Sandlund JT, et al. Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia. Eur J Cancer. 2014;50(15):2685–94.PubMedCrossRef Bhojwani D, Darbandi R, Pei D, Ramsey LB, Chemaitilly W, Sandlund JT, et al. Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia. Eur J Cancer. 2014;50(15):2685–94.PubMedCrossRef
26.
go back to reference French D, Hamilton LH, Mattano LA Jr, Sather HN, Devidas M, Nachman JB, et al. A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children’s Oncology Group. Blood. 2008;111(9):4496–9.PubMedCentralPubMedCrossRef French D, Hamilton LH, Mattano LA Jr, Sather HN, Devidas M, Nachman JB, et al. A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children’s Oncology Group. Blood. 2008;111(9):4496–9.PubMedCentralPubMedCrossRef
27.
go back to reference Relling MV, Yang W, Das S, Cook EH, Rosner GL, Neel M, et al. Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. J Clin Oncol. 2004;22(19):3930–6.PubMedCrossRef Relling MV, Yang W, Das S, Cook EH, Rosner GL, Neel M, et al. Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. J Clin Oncol. 2004;22(19):3930–6.PubMedCrossRef
28.
go back to reference Hirata T, Fujioka M, Takahashi KA, Arai Y, Asano T, Ishida M, et al. ApoB C7623T polymorphism predicts risk for steroid-induced osteonecrosis of the femoral head after renal transplantation. J Orthop Sci. 2007;12(3):199–206.PubMedCrossRef Hirata T, Fujioka M, Takahashi KA, Arai Y, Asano T, Ishida M, et al. ApoB C7623T polymorphism predicts risk for steroid-induced osteonecrosis of the femoral head after renal transplantation. J Orthop Sci. 2007;12(3):199–206.PubMedCrossRef
29.
go back to reference Karimova EJ, Rai SN, Wu J, Britton L, Kaste SC, Neel MD. Femoral resurfacing in young patients with hematologic cancer and osteonecrosis. Clin Orthop Relat Res. 2008;466(12):3044–50.PubMedCentralPubMedCrossRef Karimova EJ, Rai SN, Wu J, Britton L, Kaste SC, Neel MD. Femoral resurfacing in young patients with hematologic cancer and osteonecrosis. Clin Orthop Relat Res. 2008;466(12):3044–50.PubMedCentralPubMedCrossRef
30.
go back to reference Bernbeck B, Christaras A, Krauth K, Lentrodt S, Strelow H, Schaper J, et al. Bone marrow oedema and aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukaemia or non-Hodgkin-lymphoma treated with hyperbaric-oxygen-therapy (HBO): an approach to cure?—BME/AON and hyperbaric oxygen therapy as a treatment modality. Klin Padiatr. 2004;216(6):370–8.PubMedCrossRef Bernbeck B, Christaras A, Krauth K, Lentrodt S, Strelow H, Schaper J, et al. Bone marrow oedema and aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukaemia or non-Hodgkin-lymphoma treated with hyperbaric-oxygen-therapy (HBO): an approach to cure?—BME/AON and hyperbaric oxygen therapy as a treatment modality. Klin Padiatr. 2004;216(6):370–8.PubMedCrossRef
31.
go back to reference Lackner H, Benesch M, Moser A, Smolle-Juttner F, Linhart W, Raith J, et al. Aseptic osteonecrosis in children and adolescents treated for hemato-oncologic diseases: a 13-year longitudinal observational study. J Pediatr Hematol Oncol. 2005;27(5):259–63.PubMedCrossRef Lackner H, Benesch M, Moser A, Smolle-Juttner F, Linhart W, Raith J, et al. Aseptic osteonecrosis in children and adolescents treated for hemato-oncologic diseases: a 13-year longitudinal observational study. J Pediatr Hematol Oncol. 2005;27(5):259–63.PubMedCrossRef
32.
go back to reference Jager M, Zilkens C, Westhoff B, Jelinek EM, Kozina G, Krauspe R. Efficiency of iloprost treatment for chemotherapy-associated osteonecrosis after childhood cancer. Anticancer Res. 2009;29(8):3433–40.PubMed Jager M, Zilkens C, Westhoff B, Jelinek EM, Kozina G, Krauspe R. Efficiency of iloprost treatment for chemotherapy-associated osteonecrosis after childhood cancer. Anticancer Res. 2009;29(8):3433–40.PubMed
33.
go back to reference Leblicq C, Laverdiere C, Decarie JC, Delisle JF, Isler MH, Moghrabi A, et al. Effectiveness of pamidronate as treatment of symptomatic osteonecrosis occurring in children treated for acute lymphoblastic leukemia. Pediatr Blood Cancer. 2013;60(5):741–7.PubMedCrossRef Leblicq C, Laverdiere C, Decarie JC, Delisle JF, Isler MH, Moghrabi A, et al. Effectiveness of pamidronate as treatment of symptomatic osteonecrosis occurring in children treated for acute lymphoblastic leukemia. Pediatr Blood Cancer. 2013;60(5):741–7.PubMedCrossRef
34.
go back to reference Padhye B, Dalla-Pozza L, Little DG, Munns CF. Use of zoledronic acid for treatment of chemotherapy related osteonecrosis in children and adolescents: a retrospective analysis. Pediatr Blood Cancer. 2013;60(9):1539–45.PubMedCrossRef Padhye B, Dalla-Pozza L, Little DG, Munns CF. Use of zoledronic acid for treatment of chemotherapy related osteonecrosis in children and adolescents: a retrospective analysis. Pediatr Blood Cancer. 2013;60(9):1539–45.PubMedCrossRef
Metadata
Title
Incidence, risk factors, and treatment outcome of symptomatic osteonecrosis in Taiwanese children with acute lymphoblastic leukemia: a retrospective cohort study of 245 patients in a single institution
Authors
Shih-Hsiang Chen
Tsung-Yen Chang
Tang-Her Jaing
Mel S. Lee
Chao-Jan Wang
Iou-Jih Hung
Chao-Ping Yang
Publication date
01-07-2015
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 1/2015
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-015-1790-4

Other articles of this Issue 1/2015

International Journal of Hematology 1/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine